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Abstract.  12(S)-HETE, a lipoxygenase metabolite of 
arachidonic  acid induced a nondestructive and revers- 
ible endothelial cell (EC) retraction.  12(S)-HETE in- 
duced EC retraction was inhibited by protein kinase C 
inhibitors calphostin C  and staurosporine but not by 
the protein kinase A  inhibitor HS.  The role of EC 
integrins  otv/33 and ot5/31 in  12(S)-HETE induced EC 
retraction was investigated.  In confluent EC cultures, 
ctv~/3 is localized to focal adhesions at both the cell 
body and cell-cell borders and is colocalized with 
vinculin-containing  focal adhesions.  In contrast,  c~5/31 
is primarily enriched at the cell-cell borders, demon- 
strating  codistribution with cell cortical microfilaments 
and extraceUular fibronectin. Both receptors were 
functional in mediating cell-cell or cell-matrix interac- 
tions based on the observations that specific antibodies 
inhibited EC adhesion to intact subendothelial matrix 
and disrupted the monolayer integrity.  12(S)-HETE in- 
duced a multistep, temporally defined redistribution of 
the o~v/33-containing  focal adhesions,  leading to an 
eventual decrease in otv/33 plaques in the retracted 
ECs.  This effect of 12(S)-HETE was inhibited by cal- 
phostin C but not by H8. The alterations of o~v~3- 
containing  focal adhesions preceded the development 
of EC retraction.  12(S)-HETE also enhanced EC 
otv/33 surface expression as revealed by immunofluo- 
rescence, flow cytometry, and digitized image analysis. 
12(S)-HETE-induced o~v/33 rearrangement  (i.e.,  de- 
creased focal adhesion localization and enhanced sur- 
face expression) did not result from altered mRNA 
transcription  (as revealed by semi-quantitative RT-PCR 
analysis) or protein translation  (as revealed by Western 
blotting). In contrast to its effect on c~v/33, 12(S)-HETE 
did not demonstrate a temporally related,  well-defined 
effect on the distribution pattern and the surface expres- 
sion of ot5/31, although the cell-cell border staining 
pattern of ot5/~l was disrupted due to EC retraction.  It 
is concluded that  12(S)-HETE-induced decrease of 
c~v/33 localization to focal adhesions may contribute to 
the development of EC retraction and that 12(S)-HETE 
induced increase in ~v~3 surface expression may pro- 
mote adhesion of inflammatory leukocytes as well as 
tumor cells to endothelium. 
NDOTHELIAL cells (ECs) ~ express diverse cell  sur- 
face receptors which mediate cell-cell and cell-ma- 
trix interactions.  Among these receptors are Ca  2+- 
dependent and -independent  adhesion molecules involved in 
intercellular  adhesion (Bavisotto et al., 1990; Albelda et al., 
1990) and integrins mediating both cell-cell and cell-matrix 
interactions  (Ruoslahti,  1991). All integrins  are transmem- 
brahe heterodimers composed of  c~ and/~ subunits and are con- 
nected, via the carboxyl-terminal end of either the o~ chain 
or the/~ chain (or both), to the eytoskeleton (primarily micro- 
filament),  thus possibly establishing  an inductive communi- 
cation across the membrane. Originally,  these glycoprotein 
complexes were classified into three major subfamilies (El, 
/~2, and/~3) based on a common/3 subunit in association with 
1. Abbreviations  used in this paper: EC, endothelial cell; ECM, extracellu- 
lar matrix; HETE, hydroxyeicosatetraenoie  acid; PKA, protein kinase A; 
PKC, protein kinase C; RT-PCR, reverse transcription PCR. 
different o~ subunits  (Hynes, 1987).  However, other ~/sub- 
units expressed on epithelial cells, fibroblasts, or some carci- 
noma cells have been described. To date, at least 20 integrins 
formed from various combinations  of 12 ot subunits and 9 
subunits  have been reported (Ruoslahti,  1991; Hynes and 
Lander,  1992; Honn and Tang, 1992). 
Knowledge of EC integrins stemmed from the observation 
that vascular ECs synthesize a membrane protein that is im- 
munologically  and biochemically related to the platelet gly- 
coprotein otllb//33 complex (Fitzgerald  et al.,  1985).  EC 
otlIb//33-1ike receptors were later identified to be the vitro- 
nectin  receptor (otv#3),  which shares  the/33 subunit with 
otlIb//~3 and mediates EC adhesion  to fibrinogen,  vitronec- 
tin,  von Willebrand  factor (Cheresh,  1987; Dejana et al., 
1990; Albelda et al., 1989), thrombospondin (Lawler et al., 
1988), laminin (Kramer et al., 1990), fibronectin (Cheng et 
al., 1991; Charo et al., 1990), and possibly collagen (Agrez 
et al.,  1991). The reason why ctv/~3 is such a promiscuous 
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(in contrast to o~5/31, which specifically  mediates cell adhe- 
sion to fibronectin) may be explained by the fact that the ore 
subunit,  in addition to E3, is able to associate with several 
other E subunits, such as El, E5, E6,/~8, and a Es subunit 
in an osteosarcoma cell line (for review see Honn and Tang, 
1992;  Hynes and Lander, 1992),  Thus far members of two 
integrin subfamilies have been identified on ECs:  the VLA 
subfamily (El) and the cytoadhesins  (E3).  Of the six a  sub- 
units in the/31  subfamily, t~2, ,3,  and c~5 have been found 
on both large vessel and microvascular ECs (Albelda et al., 
1989; Cheng and Kramer, 1989; Kramer et al., 1990), while 
,1 and ct6 subunits appear to be present only on microvessel 
ECs (Kramer et al.,  1990;  Giltay and van Mourik,  1988). 
Interestingly,  both types of ECs appear not to express  or4 
(Albelda et al.,  1989;  Kramer et al.,  1990). Although ECs 
apparently lack E2 integrins  which participate in cell-cell 
adhesions, EC integrins also appear to play an essential role 
in maintaining endothelial monolayer integrity (Lampugnani 
et al.,  1991; and this study). 
We previously reported that a lipoxygenase metabolite of 
arachidonic acid 12(S)-hydroxyeicosatetraenoic  acid [12(S)- 
HETE]  induced an extensive retraction of large vessel ECs 
(Honn et al., 1989). Recently, we observed that 12(S)-HETE 
produced  a  similar  effect  on capillary  ECs  (Tang et  al., 
1992). The effect appeared to be mediated via actvafion of 
protein kinase C (PKC) and phosphorylation ofEC cytoskel- 
etal proteins,  subsequently  rearranging vinculin-containing 
adhesion plaques,  actin  microfilaments,  and  intermediate 
filament vimentin (Tang et al.,  1992). Integrins play an es- 
sential  role in linking  the cytoskeleton to the extracellular 
matrix (ECM) and maintaining  the integrity  of EC mono- 
layer (Lampugnani et al., 1991). Our work has demonstrated 
that 12(S)-HETE enhances the surface expression and mod- 
ulates the function of integrin aIIb/E3 on tumor cells (Grossi 
et al.,  1989; Chopra et al.,  1991). Therefore, in the present 
study, we investigated the effect of 12(S)-HETE on EC inte- 
grins,  i.e.,  avE3 and a5E1.  The results  demonstrate  that 
12(S)-HETE rearranges and disrupts  otvE3-enriched focal 
adhesions, but has little defined effect on ot5E1. In addition, 
12(S)-HETE increases the surface expression of avE3 in mi- 
crovascular ECs. 12(S)-HETE-induced  disruption of av/$3- 
containing  focal adhesions may contribute to EC retraction 
and  12(S)-HETE-enhanced  avE3  surface  expression may 
promote tumor cell and leukocyte adhesion to vascular EC. 
Materials and Methods 
Cell Culture 
Microoascular ECs (CD3) were isolated from mouse pulmonary microves- 
sels,  cloned and characterized as  described previously  (Chopra et al., 
1990).  Large vessel ECs (rat aortic EC or RAEC) were isolated from 
Sprague-Dawley  rat aortic rings as described p~viously (Diglio  et ai., 
1982). These ECs were routinely maintained in DME supplemented with 
10% FCS (GIBCO BRL, Gaithersburg, MD). Cells were cultured in a hu- 
midified atmosphere with 5% CO2, and the culture medium was changed 
every 48 h. 
Chemicals and Antibodies 
12(S)-HETE  was  purchased from Cayman  Chemical (Ann Arbor, MI). 
Type IV collagen and laminin  were isolated from Englebreath-Holm-Swarm 
murine sarcomas (Chemicon, Segundo, CA). Fibronectin was isolated from 
human plasma by affinity chromatography (GIBCO BRL). Vitronectin was 
affinity purified from bovine serum using monospecific antibodies (GIBCO 
BRL).  The protein kinase inhibitor, staurosporine (the ICso values  for 
PKC =  0.0027 #M, for PKA =  0.0082 t~M, for cGMP-dependent protein 
kinase -- 0.031 #M, and for myosin light chain kinase =  0.0019 #M), was 
obtained from BIOMOL Res. Labs.  Inc., (Plymouth Meeting,  PA). PKC 
inhibitor, caiphostin C (the ICso values for PKC  =  0.05 #M, for PKA > 
50 #M, for cGMP-dependent protein kinase >25 ~tM, and for myosin light 
chain kinase >5 #M),  was isolated from Cladosporium cladosporioides 
(Kamiya Biochem Co., Thousand Oaks, CA). The protein kinase A (FKA) 
inhibitor, H8 (the ICso values for PKC =  15 #M, for PKA -- 1.2 #M, for 
cGMP-dependent protein kinase = 0.48 #M, and for myosin light chain ki- 
nase =  68 #M), was purchased from Seikngaku America, Inc. (St. Peters- 
burg, FL). Rhodamine-conjngated  pballoidin was purchased from Molecu- 
lar Probes Inc. (Eugene,  OR). Fhorescein (FITC)- or Rhodamine-labeled 
goat anti-mouse, rabbit anti-goat and goat anti-rabbit IgG were obtained 
from ICN (Lisle,  IL).  Monoclonai anti-vinculin antibody was purchased 
from the Boeringer Mannheim  Corp. (Indianapolis, IN). A mAb against hu- 
man platelet glycoprotein  ~IIb//33 (7E3)  which cross reacts with the EC 
c~v~3 but not a5~l (Fitzgerald and Phillips, 1989; Cbaro et al., 1987), was 
kindly provided by Dr. B. S. Coller (Stony Brook, NY).  A mAb (OPG-2) 
recognizing  the/33 subunit was kindly provided by Dr. T. J. Kunicki (The 
Blood Center, WI). Polyclonal anti-otv/~3  and anti-~5/~l were raised in rab- 
bit (Chemicon International, Temecnia,  CA).  Goat antibody to 0~5/31 and 
monoclonal anti-human o~v (clone VNR 147) were obtained from Telios 
Pharmaceuticals Inc. (San Diego, CA). The specificity of these antibodies 
was characterized by immunoblotting and immunoprecipitation. Two poly- 
clonal antibodies to ~5/~1 stained identical bands on Western blots, i.e., a 
ll0-kD band under nonreducing conditions and a  130-kD band under re- 
ducing conditions (data not shown), which represents the/~1 subunit of the 
c~5~31 receptor.  Rabbit anti-otv~3 immunoprecipitated a 110- and a 130-kD 
band under reducing conditions and a 90- and a 150-kD band under nomeduc- 
ing conditions (data not shown), which corresponded to the 83 and ~v sub- 
units, respectively. Rabbit anti-c~5/~l, under reducing conditions, immuno- 
precipitated a 130- and a 135-kD band, which corresponded to the ~1 and 
c~5 subunits, respectively (data not shown). This antibody immunoprecipi- 
rated a 155-kD (a5) band and a ll0-kD (~1) band from surface-labeled  CD3 
ceils under nonreducing conditions (data not shown).  Monoclonal anti- 
human a5 was purified from mouse ascites fluid by nondenaturing liquid 
chromatography (Oncogene Sciences, Manhasset, NY). Nonimmune rabbit 
IgG (Copper Biochemical,  Malvern, PA) and MOPC 21 tumor cells ascites 
(Sigma Immunochemicals, St.  Louis, MO) were used as polyclonal  and 
monoclonal antibody controls, respectively. Goat whole serum (Sigma Im- 
munochemicals) was used to block nonspeciflc  Fc receptors. 
Cell Plating 
Glass coverslips were cleaned by sonication in 70% ethanol for 30 rain and 
dried, 1 ×  105 of the ECs were plated onto treated cooerslips (18 mm  2) and 
cultured  in DME supplemented with 10%  FCS.  Higher density of ceils 
(1  x  106) was plated for those experiments  using confluent cells and the 
cells were cultured for 3--4 d to reach full confluence. To determine whether 
the expression of VnR and FnR in ECs is dependent on the specific substra- 
tum, ECs were seeded onto glass coverslips  coated with fibronectin (10 
/~g/nd), laminin (20 #g/ml), fibrinogen (10 ~tg/ml), type IV collagen  (20 
~g/ml), or vitronectin (10 ~tg/mi). These substrate proteins were recon- 
stituted to their respective final concentrations in PBS, and 100 #1 of the 
solution was laid on coverslips  (18 mm  2) for 2 h at 37"C. After washing, 
the coated eoverslips were further incubated with 2% BSA in PBS for an- 
other half an hour to block unoccupied binding sites. Then 1 x  105 of ECs 
were seeded onto the coverslips  and cultured in the absence of serum for 
3 h before treatment (see below). 
Preparation of  Intact ECM 
In  some  experiments  (e.g.,  adhesion study),  ECM  sheet derived from 
confluent ECs was used as the adhesion substrate.  Confluent ECs were re- 
mooed by incubation with 25 raM ammonium hydroxide for 20 rain at 25°C. 
The integrity and uniformity of the obtained ECM was characterized as pre- 
viously described (Menter et al.,  1987). 
Eicosanoid Treatment 
Cells were washed with DME and then treated with 0.1 #M of 12(S)-HETE 
in DME for 5 min. The same amount of absolute ethanol (solvent) was used 
as the control. After the treatment, the cells were washed twice and then col- 
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cells were treated with different concentrations of 12(S)-HETE or corre- 
sponding amounts of  ethanol for 15 rain at 37°C. In some experiments (e.g., 
flow cytometry studies), cells were continuously exposed to the eicosanoid 
in 4% BSA (in DME) for different periods of time. 
Protein Kinase Inhibitor Studies 
To examine the role of different protein kinases in the 12(S)-HETE effect, 
several general or specific protein kinase inhibitors wore used in the EC 
retraction assay and immunnfluorescence, i.e.,  staurosporine (which in- 
hibits the catalytic domain of PKC and other protein kinases), calphostin 
C  (which preferentially interacts with the regulatory  domain of PKC; 
Tamaoki,  1991),  and H8 (which has markedly higher affinities to cyclic 
nucleotide dependent protein kinases than other kinases; Hidaka et al., 
1991). For the dose and time studies, staurosporine (at the doses of 0.005, 
0.05,  and 0.5/~M), calphostin C  (at the doses of 0.05,  0.5,  and 5 ~M) or 
H8 (at the doses of 0.05, 0.5, 5 and 50/tM) was added, together with 12(S)- 
HETE (0.1 ~M) or ethanol, to the culture medium. The EC monolayer was 
monitored by phase contrast microscopy at timed intervals, i.e., at 15, 30, 
45, and 60 min after addition. 
EC Retraction Assay 
To quantitatively determine the role of different protein kinases in 12(S)- 
HETE-induced EC retraction, we performed the EC retraction assay in the 
presence of kinase inhibitors, using our established protocol (Honn et al., 
1989).  Briefly, confluent CD3 cells grown on collagen IV in 96-well plates 
were treated with 12(S)-HETE (0.1/~M) or ethanol, or 12(S)-HETE plus 
different doses of inhibitors (see above) for 30 rain. Then the cells were 
washed (three times in PBS), fixed, and incubated with 125I-labeled mAb 
to collagen type IV (Collaborative Res.; 45 rain, 27 ~g total protein; 1.2 
x  105 cpm/~g protein/well). The contents of the wells were washed (3  x 
with PBS) and removed with 1 ml of 0.5% trypsin and 0.5% type IV col- 
lagenase  and  counted  using  a  Minaxi  (AUTO-GAMMA  5000  series) 
gamma counter (Packard Instrument Company, IL). The results were ex- 
pressed as total cpm/well. Each condition was run in triplicate and the ex- 
periment was repeated three times with comparable results. 
Flow Cytometric  Analysis of EC Surface Expression 
of lntegrin Receptors 
ECs were nonenzymatically removed from the culture flasks. Briefly, cells 
were incubated for 15 min in 5 mM EDTA in PBS containing 0.5 % BSA 
and 10 mM PMSF and then detached by gentle pipetting. Subsequently, 
cells were washed once with serum-free DME.  Cell treatment was per- 
formed at 37°C for 15 min with different doses of 12(S)-HETE (0.01, 0.1, 
0.5 and 1.0 ~M) or equivalent amounts of ethanol. After washing, cells were 
fixed with 0.1% sodium azide (in PBS containing 1% BSA) for 20 min on 
ice. At the end of fixation, cells were washed twice and blocked with normal 
goat serum (in PBS containing 2% BSA) for 20 rain at 4°C. Thereafter, the 
cells were incubated with rabbit anti-oct/53 or rabbit (or goat) anti-c~5/31 
(1:40) for 45 rain at 4°C. After washing, the cells were incubated with FITC- 
conjugated goat anti-rabbit or rabbit anti-goat IgG (1:200 in PBS contain- 
ing 4%  BSA) for 45  min at 4°C.  Finally, cells were postfixed with 1% 
paraformaldehyde for 15 rain. Samples were measured with an Epics Profile 
II flow cytometer (Coulter, Hiaieah, FL) for fluorescence intensity. The 
data were analyzed by comparing the relative fluorescence (Grossi et al., 
1989)  or mean log fluorescence. 
Immunofluorescence 
After treatment with 12(S)-HETE or 12(S)-HETE plus kinase inhibitors, 
ECs grown on various substrates were fixed with 3.7%  paraformaldehyde 
in PBS (containing 1 mM of Ca  2+ and Mg  2+, and 5 % sucrose, pH 7.4) for 
15 rain. After washing with PBS, the residual aldehyde groups were neutral- 
ized with 1% NH4C1 in PBS. For surface integrin labeling, cells were in- 
cubated with 20% normal goat whole serum in 4% BSA-PBS at 37°C for 
30 rain to block the nonspecific binding. For intracellular labeling, cells 
were first permeabilized with the extraction buffer (20 mM HEPES, 300 
mM sucrose, 50 mM NaCI,  3  mM CaC12 and 0.5%  Triton X-100)  for 
3 rain, then blocked with the goat whole serum. After extensive rinsing, 
cells were reacted with various primary antibodies, i.e., monoclonal anti-olv 
and anti-c~5, 7E3 (at the final concentrations of 10 ~tg/mi), or polyclonal 
anti-c~5Ol and anti-c~v/33 (at the final concentrations of 30 ~,g/rnl). Then 
cells were incubated with FITC-conjngated goat anti-mouse, goat anti- 
rabbit or rabbit anti-goat IgG (1:200)  for 45 min at 37°C. To double-label 
microfilaments and av/33 or (x5~l, a secondary antibody mixture of FITC- 
conjugated rabbit anti-goat IgG and Rbodamine-conjugated phalloidin was 
used. Double labeling of vinculin and av/33 or vinculin and cc5/51 was per- 
formed using a mixture of  primary antibodies (i.e., 10 ~g/ml of monoclonal 
anti-vinculin and rabbit anti-oc¢/~3 or -c~5/31) and a mixture of secondary an- 
tibodies (i.e., goat anti-mouse IgG-FITC and goat anti-rabbit IgG-rho- 
damine). Samples were mounted on clear slides with glycerol-PBS (9:1) 
containing 0.1% p-phenylenediamine to retard fluorescence fading. Fluo- 
rescence microscopy was performed using a Nikon Orthoplan microscope. 
Micrographs were recorded on Kodak T-Max 400 panchromatic films (East- 
man Kodak Co., Rochester, NY). 
Quantitation of cxv83 and c~5131 Surface Expression 
by Fluorescence  Imaging (ACAS  Analysis) 
To further evaluate the effect of 12(S)-HETE on the surface expression of 
c~v/33 and a5~l integrins on ECs and to circumvent the potential influence 
of cell dissociation using EDTA on the integrin surface labeling, adherent 
CD3 cells on coverslips stained as described for immunofluorescence were 
analyzed for fluorescence intensity using the ACAS 470 argon laser fluores- 
cence imaging cytometer (Meridian Instruments, Okemos, MI). This auto- 
mated digital imaging system determines the subeellular distribution and 
the in situ expression of interested molecules in single cells or in a popula- 
tion of cells. CD3 cells (either 70% confluent or confluent) grown in 33- 
mm  2 petri dishes were treated with 12(S)-HETE and then surface labeled 
as described for immunoflunrescence  using either rabbit anti-c~v~3 or rabbit 
anti-c~5~l.  The secondary antibody used was goat anti-rabbit IgG con- 
jugated to FITC. Samples were loaded onto the stage of the laser image ana- 
lyzer and the surface expression of these two integrin receptors determined. 
The system uses laser irradiation to effect fluorescence excitation. ~  la- 
bel was excited with the argon laser beam at 488 ran, and the fluorescence 
emission measured above 530 nm using a 530/30-nm longpass filter.  The 
intensity of each single point emission was recorded and displayed as a 
color-coded image. Fluorescence intensity is given in arbitrary units per 
pixel. At least five areas randomly chosen in each sample were analyzed 
and each condition was run in triplicate. The experiments were repeated 
with comparable results. 
Adhesion Assay 
In vitro antibody inhibition studies were performed to determine  the relative 
functions of c~v/33 and c~5/~1 in mediating EC adhesion to and spreading on 
intact ECM.  CD3  cells were detached with trypsin (0.01%)  and EDTA 
(1 mM) and allowed to recover in serum-containing medium for 30 rain at 
37°C. After washing, 1 ×  105 of suspended cells were put into one of the 
24-well plates (Falcon) and the adhesion was conducted in the presence of 
various dilutions of rabbit anti-o0053 and goat anti-c~5~l,  monoclonal anti- 
cdIb//33 (7E3), or equivalent amounts of nonimmune rabbit IgG (in DME 
without serum) for 30 rain at 37°C. The assay was stopped by aspirating 
off nonadherent cells, washed and then fixed with 3.7% paraformaldehyde. 
Each condition was run in quadriplicate and the experiment was repeated 
at least three times with comparable results. The number of adherent cells 
was determined as described previously (Honn et al.,  1989). 
Antibody Perturbation Study 
Specific antibodies to ccv/53 and c~5/31 or to the separate subunits (i.e., oN 
and c~5) were used to determine the roles of these two intagrin receptors 
in maintaining the integrity of EC monolayer. Confluent CD3 cells grown 
on uncoated coverslips were washed twice with DME containing 2% BSA. 
Rabbit anti-av/53,  rabbit anti-c~5jS1 or nonimmune rabbit IgG (final concen- 
tration 30 ~g/ml), or monoclonal anti-o~v, monoclooal anti-c~5, monoclonal 
7E3 or MOPC ascites (final concentration 10/tg/ml) were diluted with 1% 
FCS-contalning DME. 200/zl of the above solution was added onto each 
coverslip. Then ECs with the various antibodies or control IgG fractions 
were cultured for different intervals at 25°C, and the integrity of the EC 
monolayer was monitored by both phase-contrast microscopy and F-actin 
staining using phalloidin. Cells were fixed at several time points, i.e.,  15 
rain, 30 min,  1, 2, and 24 h after antibody addition. 
Immunoblotting 
Unlabeled CD3 cells were scraped off the culture flasks into the TNC lysis 
buffer (0.01 M Tris-acetate, pH 8.0, 0.5% NP-40, and 5 mM Ca  2+) contain- 
ing a cocktail of protease inhibitors (10 mM PMSF, 1 mM leupeptin, 1% 
Tang et al. 12(S)-HETE  Rearranges Endothelial Cell ctv~3  691 aprotinin, 1 #g/ml of pepstatin and chymostatin) and extracted on ice for 
20 rain. The whole cell lysates were centrifuged at 14,000 g to obtain the 
supernatants.  Proteins were separated on 7.5%  SDS-PAGE under both 
reducing (5 % 2-mercaptoethanol) and nonreducing conditions. Then pro- 
teins were transferred to nitrocellulose membrane and the target proteins 
were detected using the ECL  (Enhanced Chemiluminescence) Western 
blotting detection kit (Amersharn, Arlington Heights, IL) as described pre- 
viously (Tang  et al.,  1993).  To quantitatively determine whether 12(S)- 
HETE  alters  the  protein  level  of ctv/$3  integrin,  confluent  CD3  cell 
monolayers grown in six-well culture plates were treated with 0.1 #M 12(S)- 
HETE or ethanol for 5 min and then transferred to FCS-containing DME 
and cultured for different time intervals (i.e., 5,  15, 30, 60, and 120 min). 
Ceils were harvested with the TNC lysis buffer and the supernatants ob- 
tained as described above. An equal amount of protein (as determined by 
Bradford) was loaded onto a denaturing 7.5 % SDS-PAGE under reducing 
conditions and proteins transferred to  nitrocellulose paper as described 
above. The amount of av/$3 integrin was probed by a monoclonal antibody 
(OPG-2) recognizing the/$3 subunit and the intensity of the band deter- 
mined by scanning using an XL Ultrasean densitometer. 
Semi-quantitative RT-PCR 
To determine whether 12(S)-HETE has any effect on the 00//33 and c~5/31 
expression at the transcriptional level, the integrin mRNAs were amplified 
by RT-PCR (Chen et al., 1992) and quantitated by Southern blotting using 
cry, ors, /$1, or/$3 cDNA as respective probes. Total  RNA was extracted 
from confluent CD3 cells (treated with ethanol or 0.1 #M of 12(S)-HETE 
for 1, 4, or 24 b) with guanidinium thiocyanate-CsCl method (Chang et al., 
1992).  One gg of total RNA was reverse transcribed in 20 #l solution con- 
taining 50 mM "Iris (pH 8.3), 75 mM KCI, 3 mM MgCl2,  10 mM DTT, 
0.5 mM dNTPs, 20 U of RNasin (Promega),  1 /zM of anti-sense primer, 
200 units of M-MLV reverse transcriptase (GIBCO BRL) at room tempera- 
ture for 15 min then at 37°C for 1 h. To the 20 #l of reverse transcriptase 
reaction, 1 #M of the sense primer, 80 #l of 1 x  PCR buffer (20 mM Tris 
pH 8.3, 50 mM KC1, 2.5 mM MgCl2,  0.1 mg/ml BSA) and 1 U AmpliTaq 
DNA polymerase (Perkin Elmer Corp.,  Norwalk,  CT)  were added and 
PCR was run in the GeneAmp PCR system 9600 (Perkin Elmer Corp.) 30 s 
at 94°C, 30 s at 50°C, and 1 min at 72°C for 30 cycles. The sense primers 
used in RT-PCR  were 5'-CATTTCCGAGTCTGGGCCAA-3' (as), 5'-TGT- 
TCAGTGCAGAGCCTTCA-3'  (fit),  5'-GGGGACTGCCTGTGTGACTC-Y 
(~3).  The  anti-sense primers  were 5'-TGGAGGCTTGAGCTGAGCTT-Y 
(cts), 5'-CCTCATACTTCGGATTGACC-Y  (/30 and 5'-CTTTTCGGTCGT- 
GGA'IGGTG-3' (/$3). For the ctv subunit, two pairs of primers were used: 
5'-CGC_~ACCATCTCATCACTAAG-Y  (sense)  and  5'-TCTTGTTCTTCT- 
TGAGGTGGC-3' (anti-sense), and 5"GTTGGGAGATTAGACAGAGGA-Y 
(nested  sense)  and  5'-CAAAACAGCCAGTAGCAACAA-Y (nested anti- 
sense). 20 #1 of PCR-amplified cDNA was migrated on a 2% agarose gel 
and transferred to Genescreen Plus membrane (NEN, Du pont) using a Posi- 
Blot Pressure Blotter (Stratagene, La Jolla, CA). DNA was UV-linked to 
the membrane, hybridized with 32P-labeled cDNA probes and the intensity 
of the bands determined by scanning with a LKB Ultrascan XL laser densi- 
tometer. 
Results 
12(S)-HETE Induces EC Retraction which Is Inhibited 
by Calphostin C But Not by H8 
Normal CD3 ECs form tightly apposed, "cobblestone"dike 
monolayer in culture (Fig.  1 a). Treatment with 0.1 gM of 
12(S)-HETE induced a retracted cell phenotype and forma- 
tion of cell-cell gaps (Fig.  1 b). Calphostin C (Fig.  1 c), a 
selective PKC inhibitor (Tamaoki, 1991), at a dose of 0.05 
gM (data not shown) or 0.5 #M, applied together with 12(S)- 
HETE,  significantly inhibited  12(S)-HETE-induced  CD3 
cell retraction. The effect was more prominent at a higher 
dose (5 #M) of calphostin C (Fig. 1 d). By comparison, HS, 
a PKA inhibitor (Hidaka et al., 1991), at a dose of 5 #M (Fig. 
1 e) or even higher (up to 50 #M, data not shown) did not 
demonstrate any effect. Staurosporine at all doses examined 
(i.e., 0.005, 0.05, 0.5, and 5 #M) displayed less of an inhibi- 
tory effect than calphostin C on 12(S)-HETE-induced EC 
retraction (Fig.  1 f).  These inhibitors alone, at the doses 
tested,  did not significantly alter the morphology of EC 
monolayer,  although  staurosporine  at  high  doses  (e.g., 
5 #M) appeared to induce a retractive phenotype of EC by 
itself (data not shown).  Quantitative measurement of EC 
retraction using labeled anti-collagen IV binding assay (14) 
was performed to evaluate the effects of these protein kinase 
inhibitors and the results confirmed the morphological ob- 
servations (data not shown). 
Expression and Functional Characterization 
of EC av[33 and a5[31 
The subcellular distribution of ctv~3 and ct5/31 integrins in 
microvascular CD3 ECs was studied after plating cells on 
coverslips  for  various  time  periods.  These  two  integrin 
receptors demonstrated different localization patterns (Fig. 
2).  Subconfluent CD3  cells (4 h  after plating) expressed 
c~v~3 prominently at the focal adhesions, colocalizing with 
actin microfilaments (Fig. 2, a and b, arrowheads) and vin- 
culin (data not shown; also see Fig. 7). When ECs reached 
confluency, the otv/33-containing  focal adhesions were dis- 
tributed at both the cell body and cell-cell borders and con- 
tinued to colocalize with the stress fibers (Fig. 2, c and d). 
In contrast, a5/31 in microvascular ECs appeared to follow 
a different distribution pattern. In subconfluent CD3 cells 
(4 h after plating), c~5/31 did not demonstrate typical focal 
adhesion labeling, but a line- or strand-like staining pattern 
reminiscent of extracellular fibronectin staining (Fig. 2 f). 
In addition, ot5/31 demonstrated only occasional and very 
weak colocalization with stress fiber endings (Fig. 2, e and 
f  arrowhead) and vinculin-containing focal adhesions (data 
not shown; also see Fig. 7). In confluent, and especially in 
postconfluent CD3 monolayers, ct5/31 was enriched primar- 
ily and almost exclusively to the cell-cell borders (with very 
little cell body focal adhesion labeling) and codistributed 
with the cortical actin filaments (Fig.  2,  h  and g, arrow- 
heads),  demonstrating a  colocalization with extracellular 
fibronectin  (data  not  shown)  but  not  significantly with 
vinculin-containing focal adhesions (data not shown; also 
see Fig. 7). Staining of the large vessel ECs (RAEC) with 
the same antibodies revealed an identical distribution pattern 
(data not shown; also see Tang et al.,  1993).  When CD3 
microvessel ECs were plated on individual specific adhesive 
ligands, the expression of these two integrins in focal adhe- 
sions demonstrated a clear substrate dependency. CD3 cells 
expressed c~v/33 to focal adhesions when cells were plated on 
vitronectin or fibrinogen, but not on fibronectin, collagen IV 
or laminin (data not shown). Similarly, ct5/31 was enriched 
to  focal  adhesions  only  when  the  cells  were  plated  on 
fibronectin, but not on other substrates such as laminin, col- 
lagen IV, fibrinogen or vitronectin (data not shown). 
CD3 cell adhesion to intact ECM was performed in the 
presence of various concentrations of rabbit anti-ave3, 7E3 
(a monoclonal against the crib//33 complex that cross reacts 
with ctv/33 but not with ot5~l; Fitzgerald and Phillips, 1989; 
Charo et al., 1987; Grossi et al., 1989) and goat anti-a5/~l 
(Fig. 3).  The results indicated that all three antibodies in- 
hibited EC adhesion to ECM in a dose-dependent manner 
(Fig. 3 A). Experiments with rabbit anti-c~5/31 also demon- 
strated an inhibitory effect on CD3 adhesion to ECM (data 
not shown). When these antibodies or monoclonal anti-oc¢ or 
The Journal  of Cell Biology,  Volume 121, 1993  692 Figure 1.  12(S)-HETE-induced  EC retraction is inhibited by PKC inhibitor calphostin C but not by protein kinase A inhibitor H8. Shown 
are micrographs of confluent CD3 cells 45 min post treatment by ethanol (a), 0.1/zM12(S)-HETE alone (b), 12(S)-HETE (0.1 #M) plus 
0.5/zM (c) or 5/zM (d) of calphostin C, 12(S)-HETE (0.1/~M) plus 5 #M H8 (e), or 12(S)-HETE (0.1 /~M) plus 0.5 #M staurosporine 
0e). Bar, 3.5 ttm. 
andi-ot5  were added to confluent CD3 monolayers, the EC 
sheet was disrupted as revealed by both phase-contrast mi- 
croscopy (data not shown) and actin staining (Fig. 3 B). The 
antibody effect was time dependent.  15  min after adding 
polyclonal anti-o~v~3 or monoclonal anti-otv, but not other 
antibodies (i.e.,  antibodies to c~5/~1 or c~5), retracted EC 
morphology,  formation of cell-cell  gaps,  and  decreased 
staining of stress fibers were observed (data not shown). By 
60 min, as shown in Fig. 3 B, these alterations became more 
prominent with anti-oc~/~3 and anti-tx,  v (Fig.  3 B, b and c). 
7E3 demonstrated a disrupting effect comparable to that of 
the anti-av (Fig. 3 B, d). By comparison, both rabbit anti- 
c~5/~1 (Fig. 3 B, e) or goat anti-c~5/~2 (data not shown) and 
monoclonal anti-or5 (Fig. 3 B, f) produced only a slight dis- 
ruption of the EC monolayer. Rabbit IgG treatment did not 
result in any alteration of the confluent CD3 monolayer (Fig. 
3B, a). 
12(S)-HETE Redistributes EC ~v133-containing 
Focal Adhesions 
Both confluent (Fig, 4 a) and subconfluent (Fig. 4 b) CD3 
Tang et al. 12(S)-HETE  Rearranges Endothelial Cell  ctvf33  693 Figure 2.  Detection of otvO3 
and a5•l  in subconfluent (a, 
b, e, and f) and confluent (c, 
d,  g,  and  h)  microvaseular 
ECs. Shown are micrographs 
of cells double labeled for mi- 
crofilarnents with rhodamine- 
phallodin (a, c, e, and g) and 
otv/33 or  c~5~1 with  rabbit 
anti-human c~v/33 (b and d) or 
goat anti-human  ~5/31 (land 
h)  followed by  fluorescein- 
conjugated  secondary  antibody. 
Bar,  8  #m. 
cells expressed otv133 in focal adhesions at the cell body as 
well as along the cell-ceU borders (cell edges) when stained 
with polyclonal anti-otv/33. This distribution pattern is very 
similar to that of vinculin (see Fig. 7). 12(S)-HETE induced 
a similar effect on otv133 distribution to its effect on vinculin 
(unpublished observations). 12(S)-HETE induced a series of 
time-dependent  alterations  in  the  distribution  pattern  of 
otv~3-enriched focal adhesions. 5 rain after stimulation, no 
detectable  retraction  was  observed  by  light  microscopy. 
However, the typical focal adhesion labeling of o~v/~3 was 
disrupted in groups of cells in focal areas.  In these cells, 
av/~3-containing focal adhesions appeared to be "cleaved," 
The Journal of Cell Biology, Volume 121,  1993  694 Figure 3. Functional characterization of EC otv/53 and c~5/51. A, adhesion to ECM was performed with resuspended CD3 cells in the pres- 
ence of rabbit anti-otv/33 (30/~g/ml) (I), goat, or rabbit (data not shown), anti-~5/~l (30/~g/ml) (m), monoclonal anti-c~Wo//33  7E3 (10 
izg/ml) ([]), or nonimmune rabbit IgG (30 ttg/ml) for 30 min. Each condition was run in quadruplicate, the number of adhered cells 
was determined as described (Horm et al., 1989), and the results were expressed as the percentage of the adhesion relative to the control 
(rabbit IgG treatment). The SD was always  < 5 % (data not shown). B, antibody perturbation study. Confluent CD3 monolayer was incubated 
with nonimmune rabbit IgG (30 #g/rul, a), rabbit anti-c~v/33 (30 t~g/ml, b), monoclonal anti-coy  (10 #g/ml, c), 7E3 (10 #g/ml, d), rabbit 
anti-a5/31 (30 #g/ml, e), goat anti-~5/31 (30 tLg/ml; data not shown), monoclonal anti-c~5 (10 tzg/ml,  f), or MOPC ascites (10 ~g/ml, not 
shown) for different time intervals. The integrity of  the EC sheet was monitored by actin staining. Shown is 60 rain of  incubation. Bar, 8 tzm. 
leading to formation of numerous small otv/33-enriched focal 
adhesions (data not shown). As retraction developed in the 
CD3 monolayer, 15 min after 12(S)-HETE (0.1 t~M) treat- 
ment, the otv/33-contalning  focal adhesions were decreased 
at both the cell body and periphery (Fig. 4 c, single arrow- 
heads;  Fig. 4, d, double arrowheads), especially for those 
cells  in  the  retracted area.  In  some  cells  in  or  near the 
retracted area, large patches of "merged" c~v/33-containing 
focal adhesions could be observed (Fig. 4 c, double arrow- 
heads). Temporally, these patches of otv/33 were observed 
subsequent to the redistributed, "cleaved" otv/33-containing 
focal adhesions,  suggesting that the former (i.e., patches) 
might represent a further rearrangement of (xv/33-enriched 
focal adhesions. By 30 min, large areas of exposed matrix 
could be easily discerned in retracted areas (data not shown), 
and CD3 cells demonstrated a greater decrease in their cell- 
body otv/33 plaques (Fig. 4 f, double arrowheads)  and only 
a few residual "aggregated" o~v/33-containing focal adhesions 
could be observed at the cell edge (Fig. 4 f, single arrow- 
heads). 1 h after treatment, a further decrease in the staining 
of c~v/33-enriched focal adhesions was observed both in the 
cell body (Fig. 4, e and h, arrowheads) and the cell margin. 
4  h after 12(S)-HETE stimulation, cells still demonstrated 
decreased overall labeling of av/33,  especially at the cell 
edges (data not shown). By 24 h, cells recovered their nor- 
mal "cobblestone" morphology and the complete monolayer 
was reformed. There was a corresponding increase in oLv/~3- 
containing focal adhesions, both at the cell body and the cell 
periphery (Fig. 4 g). 
12(S)-HETE-induced EC ~v{33 Rearrangement Is 
Inhibited by PKC Inhibitor Calphostin C 
As in the retraction study (Fig.  1),  12(S)-HETE treatment 
(30 min) induced EC retraction and decreased o~v/33 staining 
(Fig. 5 b). Simultaneous treatment of CD3 cells with 0.1 pM 
of 12(S)-HETE and 0.5/~M of calphostin C totally inhibited 
both EC retraction and the decrease in otv/33 staining (Fig. 
5 c). However, 5 ftM or higher doses (up to 50/~M) of HS, 
a protein kinase A inhibitor, did not demonstrate any effect 
Tang et al. 12(S)-HETE  Rearranges Endothelial Cell c~vl~3  695 Figure 4.  12(S)-HETE effect on av/~3 of confluent (a, c, e, and g) and subconfluent (b, d, f, and h) CD3 cells. CD3 cells were treated 
with 0.1 #M  12(S)-HETE or equivalent amount of ethanol for 5 rain and cultured in serum-containing DME for different time points. 
¢xv433 was stained using rabbit anti-aviS3 and FITC-conjugated goat anti-rabbit  IgG after fixing and permeabilizing  cells. Shown are micro- 
graphs of CD3 cells treated by ethanol (1 h after the treatment, a  and b) or 12(S)-HETE 15 rain (c and d), 30 min (f), 60 rain (e and 
h), or 24 h (g) after treatment. Bar,  10 #m. 
The Journal of Cell Biology,  Volume 121, 1993  696 Figure 5.  12(S)-HETE-indueed rearrangement of EC otv/33 is inhibited by PKC inhibitor calphostin C. Confluent CD3 monolayer was 
exposed to ethanol (a), 0.1 #M 12(S)-HETE (b), 12(S)-HETE plus 0.5 #M calphostin C (c), 12(S)-HETE  plus 5 #M H8 (d), or 12(S)-HETE 
plus 0.5 #M staurosporine (not shown) for 30 rain. Then cells were processed for otv/33 staining using rabbit anti-oecB3.  Note that calphostin 
C strongly inhibits 12(S)-HETE-induced CD3 cell retraction and ~xv/33 rearrangement (c). H8, at even 50 #M (not shown), is ineffective. 
Bar, 10 #m. 
on 12(S)-HETE-induced EC retraction and otv/33 rearrange- 
ment (Fig. 5 d). Again, staurosporin demonstrated a less po- 
tent effect than calphostin C  (data not shown). 
12(S)-HETE Does Not Induce a Defined 
Rearrangement of  t~5[31 Integrin 
As described above, CD3 cell ct5/31 demonstrated a differ- 
ent distribution pattern from that of the a,v/33 integrin.  In 
confluent (Fig. 6 a) and especially in postconfluent (data not 
shown) CD3  monolayer, a5/31  was almost exclusively en- 
riched  to  the  cell-cell  borders  (Fig.  6  a,  arrowheads), 
colocalizing with cell cortical microfilaments and extracellu- 
lax  fibronectin but not significantly with typical vinculin- 
containing  focal  adhesions  which  are  characteristically 
localized to the cell-matrix contact sites.  Interestingly, in 
contrast to its effect on the redistribution of EC otv/33, 12(S)- 
HETE did not demonstrate any specific effect on the ot5/31 
receptor in both confluent (Fig. 6, c and e) and subconfluent 
(Fig. 6, d and f) CD3 cells. No alteration in the distribution 
pattern of a5/31  was observed preceding EC retraction fol- 
lowing 12(S)-HETE stimulation (i.e., 5 min post treatment) 
(data not shown), in contrast to the rearrangement of av/33- 
containing focal adhesions (see above) at this time point. EC 
retraction was observed at 15 min (Fig. 6 c, asterisks) and 
became intensified by 60 min (Fig. 6 e, asterisks) after treat- 
ment.  Simultaneously the typical cell-cell border staining 
pattern of tx5131 was disrupted, however, no clear pattern of 
alteration was observed. Similarly, no definitive rearrange- 
ment  or  quantitative alteration of c~5/31 integrin  was  ob- 
served in subconfluent CD3 cells (Fig. 6, compare b with d 
and f).  By  24  h,  EC  monolayer  reformed  and  typical 
cell-cell border staining of a5/31  was again observed (data 
not shown). Staining with goat anti-or5/31 revealed identical 
results (data not shown). 
Differential Effects of 12(S)-HETE on ~v/J3 
and ~5~1 May Result  from Different Distribution 
Patterns of These Two Integrins 
The mechanism by which 12(S)-HETE exerts a differential 
effect on these two integrins is at present unclear. One possi- 
ble explanation may be different subeellular localizations of 
ctv/33 and ot5B1 integrins in microvascular ECs. Double im- 
munofluorescent labeling of integrins and vinculin, a protein 
marker for focal adhesions, was performed to examine this 
Tang et al. 12(S)-HETE Rearranges Endothelial Cell c~v~33  697 Figure 6. Effect of 12(S)-HETE on c~5/~1 of confluent (a, c, and e) and subconfluent (b, d, and f) CD3 ECs. CD3 cells grown on coverslips 
were treated as described in Fig. 5 and stained for a5/31 with rabbit anti-a5/~l and FITC-conjugated goat anti-rabbit IgG. The time points 
represent 1 h after ethanol treatment (a and b), or 15 rain (c and d) or 60 rain (e and f) after exposure to 0.1/~M12(S)-HETE. Asterisks 
indicate the retracted areas. Bar, 8/~m. 
possibility. As shown in Fig. 7, os/33-containing focal adhe- 
sions  (Fig.  7  a)  demonstrated  an  identical codistribution 
with vinculin-containing focal adhesions (Fig. 7 b, double 
arrowheads). Colocalization of ¢xv/~3 and vinculin in focal 
adhesions also was observed in fully confluent CD3 mono- 
layers (data not shown). In contrast, a5/31  integrin (Fig. 7 
c) was present in strand-like structures which were reminis- 
cent of  extracellular fibronectin and they did not demonstrate 
a  significant eolocalization with vinculin-containing focal 
adhesions (Fig. 7 d, arrowheads). In confluent ECs, c~5/31 
was primarily localized to the cell-cell borders and did not 
demonstrate colocalization with  vinculin-containing focal 
adhesions  (data not shown).  Previous work demonstrated 
that  12(S)-HETE also disrupted  vinculin-containing focal 
adhesions in retracted CD3  ECs (Tang et al.,  submitted). 
Therefore, it appears that 12(S)-HETE specifically disrupts 
the integrity of focal adhesions. 
12(S)-HETE Enhances the Surface Expression 
of  av[33 But Not ~5131 
We recently observed that a 15-rain treatment of large vessel 
EC (i.e., RAEC) with 0.1 #M of 12(S)-HETE significantly 
The Journal of Cell Biology, Volume 121,  1993  698 Figure 7. Double labeling of integrins (a and c) and vinculin (b and d). Immtmofluorescent  labeling was processed as detailed in Materials 
and Methods. Subconfluent CD3 cells were labeled with rabbit anti-cxv~33 (a) or anti-c~5/ffl (c) and vinculin (b and d). Bar, 10/zm. 
increased the surface labeling for oevB3 using mAb7E3 (Tang 
et al.,  1993).  In this study, we found that 12(S)-HETE also 
stimulated the surface expression of otv:33 on microvessel 
CD3  cells.  Both  adherent  and  resuspended  (via  nonen- 
zymatic dissociation; see Materials and Methods) CD3 ceils 
were used for surface labeling of oevj33 and a5/31 integrins. 
Immunofluorescence studies (data not shown) and digitized 
image analysis (Fig.  8) using adherent ECs indicated that 
CD3 cells stimulated with 0.1 #M of 12(S)-HETE demon- 
strated enhanced surface expression of otvB3. This stimulat- 
ing effect  of 12(S)-HETE was found to be both time and dose 
dependent.  15 min of treatment by 0.1 /~M of 12(S)-HETE 
led to an increase in otv/33 surface labeling. By 1 h, the 12(S)- 
HETE effect reached peak level (Fig. 8 c) and the mean rela- 
tive fluorescence intensity (represented by the relative color 
values as shown in Fig. 8) of  at least five individual measure- 
ments in each condition was increased from 389  +  59 (ar- 
bitrary units) in control (Fig.  8 a)  to  1286  5:371  in the 
12(S)-HETE-treated (Fig. 8 c) group. As shown in the com- 
posite histogram in Fig. 8 e, there was a dramatic shift (i.e., 
increase) in the average fluorescence of the  12(S)-HETE- 
treated samples (red bars) compared with the control (green 
bars).  After 1 h, the surface expression of oev/33 rapidly de- 
creased to the unstimulated level (data not shown). No effect 
of 12(S)-HETE on the surface expression of c~5/31 was ob- 
served (Fig. 8, b, d, and  f). At the basal (i.e., unstimulated) 
level, CD3 cells appeared to express more o~5/31 than otvfl3 
on their surface (Fig.  8,  compare a  and b).  12(S)-HETE 
treatment did not significantly alter the surface expression 
level ofa5/~l (1049 5:118 in control vs 1020 +  171 in 12[S]- 
HETE-treated group) (Fig. 8, b and d). No shift in fluores- 
cence intensity of ot5/31 surface labeling was observed after 
12(S)-HETE stimulation (Fig. 8f). Quantitative flow cyto- 
metric  measurement of fluorescence intensity revealed  a 
dose-dependent effect on otvB3 surface expression by 12(S)- 
HETE (15-min  stimulation), with a maximum effect on 0.1 
/zM (increasing the fluorescence intensity by more than two- 
fold; data not shown). In contrast, 12(S)-HETE did not in- 
crease the overall surface expression of ot5/31 as revealed by 
flow cytometry using rabbit anti-a5#l  (data not shown). 
12(S)-HETE Effect on ~v~3 Is a 
Posttranscriptional Process 
12(S)-HETE demonstrated two seemingly opposite effects 
on EC oLv/33 integrin receptors, i.e., rearranging (decreas- 
ing) c~v/33 at focal adhesions and increasing ¢xv/33 surface ex- 
pression.  Semi-quantitative RT-PCR  followed by Southern 
hybridization using specific eDNA probes for different inte- 
grin subunits was performed to determine whether 12(S)- 
HETE alters ocv/33 expression at the transcriptional level. 
The same experiment was also run for c~5/31. The results in- 
Tang et al.  12(S)-HETE Rearranges Endothelial Cell <xvO3  699 Figure 8.  12(S)-HETE exhibits differential effects on the surface expression of EC c~v/~3 and t~5/~l. Adherent subeonfluent or confluent 
(data not shown)  CD3 cells were treated with ethanol (a and b) or 0.1/zM 12(S)-HETE (c and d) for 5 rain, cultured for different time 
periods (shown here is 60 min after treatment) and then surface stained for txvfl3 (a and c) or c~5/~1 (b and d) with rabbit anti-av/~3 and 
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mRNA levels of otv/~3 and o~5fll integrins. To further sup- 
port  the  concept that  12(S)-HETE-induced alterations in 
otvfl3  may  be  posttranscriptional,  quantitative  western 
blotting of/$ 3 in whole cell lysates using monoclonal anti-/S3 
antibody (OPG-2) was performed. The results indicated that 
there was no significant alterations in the overall level of fl 3 
proteins  after  12(S)-HETE  (0.1 /xM) treatment (data not 
shown), as determined by densitometric scanning. 
Discussion 
Physiologically  ECs form a continuous and polarized bound- 
ary  between  flowing  blood  and  the  underlying  tissues. 
Specific interactions of lymphocytes (Ford et al.,  1976), 
neutrophils (Belloni and Tressler, 1989),  and circulating tu- 
mor cells (Pauli and Lee,  1988;  Weiss et al.,  1989),  with 
components of the vascular wall are important for their tar- 
geting to different  tissues and their exit from circulation. The 
maintenance of normal hemostasis, the regulation of inflam- 
mation, and prevention of blood-borne tumor cells from dis- 
semination, all depend on the physical intactness of the EC 
monolayer,  which  in  turn  is  determined  by  the  well- 
organized  cell-cell  and  cell-matrix  adhesion  structures. 
Integrins are the most important transmembrane molecules 
linking ECM to intracellular cytoskeleton. Cultured large 
and small vessel ECs express a variety of/~1 integrin com- 
plexes as well as the t~IIb//33-related t~v/33 complex (Fitzger- 
ald et al., 1985;  Dejana et al.,  1990;  Albelda et al.,  1989; 
Kramer et al., 1990).  Using immunofluorescence, immuno- 
blotting, immunoprecipitation with specific antibodies, as 
well as adhesion assay and antibody perturbation study, we 
demonstrated that both large vessel (unpublished observa- 
tions) and microvessel ECs express otv/33 and u5/$1, and that 
both receptors are functional in mediating initial EC adhe- 
sion to ECM and maintaining the integrity of the established 
monolayer. It is well known that the ECM could modulate 
the organization of EC cytoskeleton and cell shape (Young 
and Herman,  1985).  Distribution of EC integrin receptors 
to  specific cell microdomains, i.e.,  the cell-cell or cell- 
matrix  contact  sites,  is  also  regulated  by  specific  ECM 
ligands (Cheng and Kramer, 1989; Dejana et al., 1988).  In 
our experiments, we also noted that the distribution of both 
et5#l and o~v/~3 in focal adhesions is dependent on specific 
substratum composition. In confluent microvessel EC mono- 
layer (i.e., EC growing on their own natural ECM), c~5/31 
and otv~3 appear to follow different  distribution patterns; the 
former  primarily  concentrated  at  the  cell-cell  borders 
colocalizing with cell cortical microfilaments and extracel!u- 
lar fibronectin while the latter codistributed with typical 
vinculin-containing focal adhesions in both the cell body and 
cell-cell borders. This different distribution pattern of otvfl3 
and  ot5/31 implies  that  these  two  integrins  may  play  a 
differential role  in mediating EC-matrix interactions and 
maintaining the EC monolayer integrity and also provides an 
explanation for the specific effect of 12(S)-HETE on otv/33. 
12(S)-HETE induced a time-dependent redistribution of 
otv/33-containing  focal adhesions and there exists a cause- 
and-effect relationship between 12(S)-HETE-induced otv/33 
rearrangement and EC retraction. 5 min after 12(S)-HETE 
stimulation when no EC retraction could be detected (both 
morphologically  and  quantitatively),  redistribution  (i.e., 
cleavage) of ctv/$3-containing focal adhesions was observed. 
Subsequently rearrangement of otv/~3 integrin led to an over- 
all decreased localization of this integrin to focal adhesions, 
the most important cellular structures linking cells to ECM 
through the cytoskeleton. The general alterations of otv/~3- 
containing focal adhesions are very similar to those of  vincu- 
lin plaques (unpublished observations), i.e., an eventual de- 
crease in those retracted ceils, implying that 12(S)-HETE 
has a global impact on the focal adhesions. Focal adhesions 
are complex cellular structures involved in transducing sig- 
nals from the outside to the inside, or vice versa, through a 
chain of proteins, i.e., extracellular adhesive glycoproteins 
such as  fibronectin and vitronectin linked to  membrane- 
spanning integrins which are further connected to cytoskele- 
ton via talin, vinculin, ot-actinin,  etc (for review,  see Bur- 
ridge et al.,  1988).  A number of regulatory proteins, such 
as tyrosine kinases (e.g., pp60  ~-s~, Burridge et al.,  1988), 
proteases (Beckerle et al.,  1987),  PKC isoforms Oaken et 
al.,  1989),  and so on, are also concentrated at focal adhe- 
sions to maintain the dynamic entity. How 12(S)-HETE al- 
ters the normal organization of otv/33 integrins is currently 
unknown, but two nonexclusive alternatives could be hy- 
pothesized. One possibility is that ctv/~3 redistribution re- 
suits from the alteration of other components of the focal ad- 
hesions,  such as microfilament, vinculin or t~-actinin.  In 
CD3 ceils, av/$3 integrin is colocalized with vinculin, stress 
fiber endings, and ot-actinin  in focal adhesions (this study 
and unpublished observations). In fact, we have found that 
12(S)-HETE rearranges vinculin-enriched focal adhesions, 
reorganizes the actin filaments, and mobilizes ot-actinin  to 
the membrane "ruffles" (Tang et al., 1992).  All of these al- 
terations would undoubtedly disrupt the normal ctv/~3-con- 
taining focal adhesions. Preliminary results obtained from 
vinculin-otv/~3 double labeling experiments suggest that al- 
teration (i.e., disruption and decrease) of vinculin-contain- 
ing focal adhesions appear to occur before that of otv/~3-con- 
taining  focal  adhesions.  The  other  possibility  is  that 
12(S)-HETE directly exerts its effect on av/33, for instance, 
through phosphorylation,  since this eicosanoid alters  the 
organization  of  the  cytoskeletal  elements  by  enhancing 
PKC-dependent phosphorylation (Tang et al., 1992). Several 
integrin subunits, including/$3, can be phosphorylated (Hil- 
lery et al.,  1991; Haimovich et al.,  1991). Interestingly, 
12(S)-HETE-induced etv/~3 rearrangement also appears to 
be dependent on PKC, since its effect could be totally abol- 
ished by the selective PKC inhibitor calphostin C, but not by 
the protein kinase A inhibitor H8. This finding is in accord 
with our recent observations that this eicosanoid induces EC 
cytoskeleton alterations in a PKC-dependent manner (Tang 
et al., 1992), and that it activates tumor cell PKC by translo- 
cating the enzyme from the cytosol to the plasma membrane 
rabbit anti-c~5/~l, respectively. After incubation with secondary antibody, cells were subjected to digitized surface fluorescence analysis 
on an ACAS  470 laser image analyzer as detailed in Materials and Methods. e andfrepresent composite histograms of a distinct population 
of CD3 cells stained for t~v/33 (e) or ct5/31 (f). Green bars, control samples: red bars, 12(S)-HETE-treated samples. Bar, 2 #m. 
Tang et al. 12(S)-HETE Rearranges Endothelial Cell etvl$3  701 (Liu et al., 1991). It would be interesting to determine which 
isoform of PKC is responsible for the 12(S)-HETE-induced 
otvB3 rearrangement.  Preliminary results indicate that, in 
addition to the PKC-ot, CD3 cells also express two other iso- 
forms. Interestingly, in all of our inhibitor studies, we ob- 
served that staurosporine is a  less effective inhibitor than 
calphostin C (based on their relative IC5o values; see Mate- 
rials and Methods) on  12(S)-HETE-induced cytoskeleton 
phosphorylation and  reorganization  (Tang  et  al.,  1992), 
avB3 rearrangement and EC retraction (this study). One pos- 
sible explanation for these observations is that staurosporine 
(which has very similar IC50 values for most protein ki- 
nases) exerts inhibitory effects on, in addition to PKC, a va- 
riety of other protein kinases including PKA, myosin light 
chain kinase and tyrosine kinases. It is known that in many 
circumstances these protein kinases play differential or an- 
tagonizing roles. Therefore, the promiscuous effects of stauro- 
sporine may mask its "specific" action on PKC. In addition, 
many  groups  have  reported  that  stanrosporine  possesses 
some biological activities (such as inducing a dissolution of 
microfilaments) independent of its effect on PKC (Hedberg 
et al.,  1990).  We also observed (both morphologically and 
quantitatively) that higher doses of staurosporine actually 
disrupted the EC monolayer integrity. 
12(S)-HETE  is a monohydroxy fatty acid and a  lipoxy- 
genase metabolite of arachidonic acid produced by plate- 
lets, leukocytes, and a variety of cell types including many 
solid tumor cells (for review, see Spector et al., 1988; Mar- 
nett et al.,  1990;  Liu et al.,  1991). During hernatogenous 
spreading of tumor cells 12(S)-HETE may reach a concen- 
tration in localized foci of tumor cell-platelet-leukocyte-EC 
interactions high enough to initiate its biological activity on 
these interacting cells. Our previous work has demonstrated 
that this eicosanoid enhances the surface expression of the 
integrin receptor cdlb//33 in cultured B16 amelanotic mela- 
noma (B16a) and Lewis lung carcinoma cells (Grossi et al., 
1989; Chopra et al., 1991). More recently, we observed that 
12(S)-HETE upregulated otv#3 integrin surface expression 
in large vessel EC, resulting in an enhanced tumor cell adhe- 
sion to the stimulated EC monolayer (Tang et al., 1993). In 
the present study, we observed that 12(S)-HETE increased, 
in a dose- and time-dependent manner, the surface expres- 
sion of otv/33 in microvessel CD3 cells, as revealed by im- 
munofluorescence studies,  digitized imaging analysis and 
flow cytometry. The expression of individual integrins is 
strictly regulated during tissue development and cell segre- 
gation.  Cell-  and  matrix-adhesion molecules,  as  well  as 
ECM components are known to respond to and be regulated 
by  signals  from  growth  factors  and  cellular  oncogenes 
(Damsky and Bernfield, 1990). Typical examples are the up- 
regulated mRNA expression of integrin receptors (all 3 ma- 
jor subfamilies) by the transforming growth factor-B (Ignotz 
et al., 1989), the downregulation of c¢v/~3 surface expression 
in ECs by  13-hydroxyoctadecadienoic acid (13-HODE),  a 
lipoxygenase metabolite of linoleic acid (Buchanan et al., 
1990),  and enhanced surface expression of otlIb/33 expres- 
sion by 12(S)-HETE in tumor cells (Grossi et al., 1989). In 
this study, we observed two effects of 12(S)-HETE on the EC 
av/~3,  i.e., a decreased focal adhesion labeling and an in- 
creased surface staining. At present, we are uncertain about 
the relationship between these two phenomena. However, it 
is highly possible that increased ctvB3 surface expression af- 
ter 12(S)-HETE stimulation may, at least partly, result from 
decreased (or mobilized) focal adhesion localization since 
these two processes appear to be temporally related. Inte- 
grins, after their synthesis, are targeted to different microdo- 
mains of  the cell such as the cell-cell border, focal adhesions 
and the cell surface. What determines the route of sorting or 
whether there is any minor difference between the integrin 
receptors targeted to different cellular microdomains is cur- 
rently unknown. What is known is that localization to each 
of these microdomains is not fixed, but under constant ex- 
change depending on the status of the cells (e.g., motile vs 
resting).  Another potential  mechanism  for  12(S)-HETE- 
enhanced t~v/33 surface expression is mobilization of this 
integrin receptor from an intracellular pool to the plasma 
membrane.  Recently we  observed  that  12(S)-HETE  en- 
hanced the surface expression of the integrin M1b/33, a close 
relative to cr¢/33, in B16a tumor cells and that this effect 
was mediated through cytoskeleton-dependent translocation 
(Chopra et al.,  1991). These results suggest that a  similar 
mechanism may exist for av133 upregulation in EC by 12(S)- 
HETE. The 12(S)-HETE effect on tumor cell MIb/33 surface 
expression was found to be time-dependent (within 1 h), in- 
dependent of transcriptional activation, but dependent on the 
tumor cell cytoskeleton, i.e., microfilaments and intermedi- 
ate filaments (Chopra et al., 1991). In this study, the stimula- 
tion of c~v/33 surface expression in CD3 ceils by 12(S)-HETE 
effect is  also  time-dependent,  and  proved  to  be  a  post- 
translational process.  Semi-quantitative RT-PCR  followed 
by Southern hybridization did not reveal  significant altera- 
tions in the mRNA levels of both cry and/33 after 12(S)- 
HETE stimulation. Semi-quantitative immunoblotting of the 
/33 subunit also did not reveal any significant alterations in 
the protein level after 12(S)-HETE treatment. It is possible 
that the increased cell surface labeling of ctv133 results from 
the  decreased  focal adhesion enrichment of this  integrin 
receptor as well as from increased protein translocation from 
a cytosolic pool to the membrane. Theoretically, decreased 
focal adhesion labeling of c~v/33 may result from decreased 
protein synthesis, however, this possibility has been excluded 
by quantitative Western blotting and RT-PCR.  Alternative 
possibilities include diminished targeting of o~v/33 to the fo- 
cal adhesions due to post-translational protein modification 
(such  as  phosphorylation),  and/or  increased  proteolytic 
cleavage  due to protease activation.  However,  at present, 
substantiative evidence for these possibilities is lacking. 
In contrast to av/33, c~5/51 did not undergo a well-defined 
and time-dependent rearrangement (e.g., redistribution and 
decrease of c~5~l-containing  focal adhesions), although the 
typical cell border  localization of o~5131 in  confluent EC 
monolayers was disrupted following 12(S)-HETE stimula- 
tion. No specific pattern of alteration in o~5/31 was observed, 
nor did 12(S)-HETE alter the surface expression of a5/31 in 
ECs.  Not  unexpectedly,  12(S)-HETE  did  not  alter  the 
mRNA level of EC ct5 or ~1. Unlike otvfl3-containing  focal 
adhesions whose rearrangement precedes  development of 
EC retraction, the disruption of cell border localization of 
o~5~1 was observed to occur simultaneously with EC retrac- 
tion. This observation suggests that the disruption of c~5131 
localization to the cell-cell borders is not an initiating factor 
in retracting ECs although it may contribute to the later 
phase of EC retraction. In microvessel ECs, integrin o~5/31, 
despite cell junction localization, appears to be less impor- 
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contact sites or focal adhesions in both the cell body and cell- 
cell borders) since anti-or5/31 antibodies are much less potent 
than anti-av/~3 in disrupting the established EC monolayer. 
Most  probably,  the  differential effect of  12(S)-HETE on 
otv/33 and c~5~1 is due to the differential distribution patterns 
of these two integrins,  i.e., av/~3, but not ol5/~1, is cedis- 
tributed with vinculin-containing focal adhesions. We con- 
clude that 12(S)-HETE appears to affect specifically the pro- 
tein components, e.g.,  microfilaments, vinculin,  cr-actinin 
and ctv/~3, in focal adhesions. 
The  significance  of  c~v/~3 rearrangement  after  12(S)- 
HETE treatment can be multi-factorial, cw/~3 is organized at 
focal adhesions and demonstrates colocalization with vincu- 
lin. In addition, it connects the intracellular cytoskeleton to 
the extracellular adhesive glycoproteins, and thus makes the 
cell and its environment an integrated system, av/~3, like vin- 
culin, is also localized to the intercellular junctions. There- 
fore we believe that 12(S)-HETE-induced disruption of this 
integrin organization will alter the normal cell-matrix and 
cell-cell adhesion, break down the EC monolayer integrity, 
and contribute to the retracted EC phenotype. The increased 
cell surface expression of oLv~3, which results from redistri- 
bution of focal adhesion-localized o~v/~3 and/or mobilization 
of av/33 from the cytosolic pool, may increase the adhesivity 
of blood-borne cells (i.e., leukocytes, tumor cells, etc.) to 
endothelium (Shaughnessy et al.,  1991; Tang et al.,  1993). 
Enhanced tumor cell adhesion and extravasation due to EC 
retraction may facilitate metastatic dissemination. Similarly, 
adhesion of leukocytes to EC and enhanced exudation of 
blood components (both cellular and acellular) may contrib- 
ute to inflammatory responses. 
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